Abstract
mRNA for the suppressive epitope of p15E was found to be present in 24 of 30 samples of human colorectal cancer and in all four specimens of gastric cancer. mRNA for p15E was seldom seen in nonmalignant colonic or gastric mucosa but, when present, was associated with inflammatory or pre-malignant conditions of the digestive tract. Synthetic peptides derived from the conserved p15E sequence were found to suppress some aspects of the immune response implicated in anti-tumour activity. These data suggest that a p15E-related material with immunomodulatory properties is elaborated within human tumours, either by the tumour itself or as a normal component of the endogenous anti-tumour reaction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Foulds, S., Wakefield, C., Giles, M. et al. Expression of a suppressive p15E-related epitope in colorectal and gastric cancer. Br J Cancer 68, 610–616 (1993). https://doi.org/10.1038/bjc.1993.395
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.395
This article is cited by
-
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
Cancer Immunology, Immunotherapy (2021)
